Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?

How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out.    Credit available for this activity expires: 03/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462 ?ecd=bdc_podcast_libsyn_mscpedu